CVS (NYSE:CVS) has announced that in order to sharpen its focus on the health of its customers it will cease selling tobacco products by October of this year. The move will cost the company billions in sales, but could it cost the tobacco industry even more if other companies follow CVS' lead?

In this segment of the Motley Fool's consumer goods show, Consumer Countdown, CG analyst Michael Finarelli joins host Mark Reeth to discuss what lies ahead for CVS and if the company is about to take down Big Tobacco.